+91-22-48913909
Fincash » Mutual Funds » Best Performing Sector Funds for 2018
Table of Contents
- Top 10 Performing Sector Mutual Funds for 2024 Based on Performance
- Best Performing Sector Funds for 2024
Top 10 Equity - Sectoral Funds
Best 10 Performing Sector Funds for 2024
Sector Mutual Funds refer to the scheme that invest a predominant stake of their fund money in equity shares of companies belonging to a particular sector. These schemes are sought after by individuals who are looking for High Returns on their investment along with a High Risk appetite. Some of the sectors in which Mutual Funds generally offer their schemes include infrastructure, pharmaceutical, banking and financial services, and natural resources and new energy. The performance of sectoral funds for the year 2024 has been considerably good. With the developments in the Economy, many of the sectoral funds have generated positive returns on their investments. So, let us look at some of the top and best 10 performing sector Mutual Funds for the year 2024 on the Basis of their performance (returns).
Talk to our investment specialist
Top 10 Performing Sector Mutual Funds for 2024 Based on Performance
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹50.505
↑ 0.68 ₹887 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹280.787
↑ 1.09 ₹1,037 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹421.735
↑ 0.75 ₹3,671 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.713
↑ 0.16 ₹1,223 40.4 36.6 -8 19.1 64.4 IDFC Infrastructure Fund Growth ₹51.059
↑ 0.55 ₹1,577 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹250.739
↑ 1.41 ₹6,485 37.3 53.6 -1.9 29.7 27.3 L&T Business Cycles Fund Growth ₹44.0129
↑ 0.60 ₹998 36.3 31.3 5.3 34.5 9.3 Canara Robeco Infrastructure Growth ₹161.42
↑ 1.32 ₹837 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹510.384
↑ 2.07 ₹8,260 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹65.48
↑ 0.56 ₹1,446 33.2 51.1 2.3 55.4 16.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 9 Jun 25
Best Performing Sector Funds for 2024
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. IDFC Infrastructure Fund is a Equity - Sectoral fund was launched on 8 Mar 11. It is a fund with High risk and has given a Below is the key information for IDFC Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Franklin India Opportunities Fund is a Equity - Sectoral fund was launched on 21 Feb 00. It is a fund with Moderately High risk and has given a Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on To seek to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian market with focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy L&T Business Cycles Fund is a Equity - Sectoral fund was launched on 20 Aug 14. It is a fund with Moderately High risk and has given a Below is the key information for L&T Business Cycles Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Canara Robeco Infrastructure is a Equity - Sectoral fund was launched on 2 Dec 05. It is a fund with High risk and has given a Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Invesco India Infrastructure Fund is a Equity - Sectoral fund was launched on 21 Nov 07. It is a fund with High risk and has given a Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.8% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (09 Jun 25) ₹50.505 ↑ 0.68 (1.37 %) Net Assets (Cr) ₹887 on 30 Apr 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.03 Information Ratio 0.32 Alpha Ratio 3.02 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,695 31 May 22 ₹19,648 31 May 23 ₹22,758 31 May 24 ₹40,600 31 May 25 ₹44,117 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 17.2% 3 Month 20.1% 6 Month -4.2% 1 Year 11.2% 3 Year 32.4% 5 Year 34.3% 10 Year 15 Year Since launch 9.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.7 Yr. Mahesh Bendre 1 Jul 24 0.92 Yr. Data below for LIC MF Infrastructure Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 57.02% Basic Materials 9.14% Consumer Cyclical 8.07% Utility 7.19% Financial Services 6.17% Real Estate 3.11% Technology 2.31% Communication Services 2.26% Health Care 0.51% Energy 0.44% Asset Allocation
Asset Class Value Cash 3.8% Equity 96.2% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹34 Cr 408,127 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹30 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹28 Cr 724,927 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001033% ₹24 Cr 1,062,199
↑ 79,197 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹24 Cr 571,332 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 22 | POWERINDIA3% ₹23 Cr 15,928
↑ 2,851 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹22 Cr 537,216
↑ 46,853 Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Oct 23 | HAL2% ₹22 Cr 49,106
↑ 3,972 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹21 Cr 476,469 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹20 Cr 126,914 2. UTI Healthcare Fund
CAGR/Annualized return of 14.9% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (09 Jun 25) ₹280.787 ↑ 1.09 (0.39 %) Net Assets (Cr) ₹1,037 on 30 Apr 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.69 Information Ratio -0.24 Alpha Ratio 0.57 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹15,428 31 May 22 ₹14,002 31 May 23 ₹14,724 31 May 24 ₹21,653 31 May 25 ₹26,840 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 6% 3 Month 8.9% 6 Month -3.2% 1 Year 21.4% 3 Year 25.3% 5 Year 21.5% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.08 Yr. Data below for UTI Healthcare Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 97.95% Basic Materials 0.97% Asset Allocation
Asset Class Value Cash 1.08% Equity 98.92% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA12% ₹123 Cr 672,889
↓ -27,111 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹62 Cr 400,000
↓ -20,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹47 Cr 396,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹47 Cr 172,829
↓ -2,056 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹41 Cr 79,763
↑ 5,763 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹38 Cr 275,250 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹34 Cr 56,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹33 Cr 63,840 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹32 Cr 465,000 3. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (06 Jun 25) ₹421.735 ↑ 0.75 (0.18 %) Net Assets (Cr) ₹3,671 on 30 Apr 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.84 Information Ratio 0.73 Alpha Ratio 2.95 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹15,765 31 May 22 ₹14,496 31 May 23 ₹16,693 31 May 24 ₹23,914 31 May 25 ₹29,485 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 0.4% 3 Month 5.7% 6 Month -2.2% 1 Year 21.9% 3 Year 27.6% 5 Year 23.7% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 91.24% Basic Materials 6.15% Asset Allocation
Asset Class Value Cash 2.6% Equity 97.4% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA14% ₹513 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹243 Cr 400,000
↑ 25,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹231 Cr 2,100,000
↓ -100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹186 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹182 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹176 Cr 840,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹139 Cr 540,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹134 Cr 2,034,372
↓ -65,628 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹117 Cr 800,000 4. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.2% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (09 Jun 25) ₹29.713 ↑ 0.16 (0.55 %) Net Assets (Cr) ₹1,223 on 30 Apr 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.52 Information Ratio 0.67 Alpha Ratio 1 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹14,898 31 May 22 ₹14,267 31 May 23 ₹15,234 31 May 24 ₹22,508 31 May 25 ₹26,301 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 3.8% 3 Month 7.9% 6 Month -3.1% 1 Year 14.7% 3 Year 23.8% 5 Year 21.1% 10 Year 15 Year Since launch 12.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.23 Yr. Rajat Srivastava 16 Sep 24 0.7 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 91.11% Basic Materials 2.29% Asset Allocation
Asset Class Value Cash 6.59% Equity 93.41% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA13% ₹157 Cr 854,300
↑ 50,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹76 Cr 490,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA6% ₹76 Cr 615,100
↓ -125,900 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹71 Cr 101,255 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹64 Cr 104,965 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹64 Cr 303,240 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹59 Cr 855,100 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹48 Cr 956,991 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹38 Cr 75,249 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG3% ₹37 Cr 666,121 5. IDFC Infrastructure Fund
CAGR/Annualized return of 12.1% since its launch. Ranked 1 in Sectoral category. Return for 2024 was 39.3% , 2023 was 50.3% and 2022 was 1.7% . IDFC Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (09 Jun 25) ₹51.059 ↑ 0.55 (1.08 %) Net Assets (Cr) ₹1,577 on 30 Apr 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio -0.13 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹20,010 31 May 22 ₹21,463 31 May 23 ₹26,973 31 May 24 ₹48,493 31 May 25 ₹48,898 Returns for IDFC Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 11.1% 3 Month 17.3% 6 Month -5.8% 1 Year 0.8% 3 Year 33% 5 Year 35.3% 10 Year 15 Year Since launch 12.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for IDFC Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.35 Yr. Ritika Behera 7 Oct 23 1.65 Yr. Gaurav Satra 7 Jun 24 0.98 Yr. Data below for IDFC Infrastructure Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 55.04% Utility 13% Basic Materials 9.55% Communication Services 5.07% Energy 4.03% Financial Services 2.72% Technology 2.49% Consumer Cyclical 2.37% Health Care 1.93% Asset Allocation
Asset Class Value Cash 3.24% Equity 96.76% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹76 Cr 443,385 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹64 Cr 452,706 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹62 Cr 330,018 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹61 Cr 183,173 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹60 Cr 4,797,143 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹59 Cr 50,452 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹45 Cr 1,431,700 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹44 Cr 365,137 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 30 Apr 15 | AHLUCONT3% ₹40 Cr 468,237 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS2% ₹39 Cr 12,400,122 6. Franklin India Opportunities Fund
CAGR/Annualized return of 13.6% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 37.3% , 2023 was 53.6% and 2022 was -1.9% . Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (09 Jun 25) ₹250.739 ↑ 1.41 (0.57 %) Net Assets (Cr) ₹6,485 on 30 Apr 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio 0.19 Information Ratio 1.89 Alpha Ratio 3 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹17,667 31 May 22 ₹17,708 31 May 23 ₹22,025 31 May 24 ₹38,020 31 May 25 ₹41,249 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 7.3% 3 Month 14.2% 6 Month -2.3% 1 Year 9.1% 3 Year 34.2% 5 Year 31.9% 10 Year 15 Year Since launch 13.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.31 Yr. R. Janakiraman 1 Apr 13 12.17 Yr. Sandeep Manam 18 Oct 21 3.62 Yr. Data below for Franklin India Opportunities Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Financial Services 19.02% Consumer Cyclical 15.92% Health Care 10.92% Technology 9.86% Communication Services 8.43% Basic Materials 8.14% Energy 6.58% Consumer Defensive 5.67% Industrials 4.86% Real Estate 2.15% Utility 1.33% Asset Allocation
Asset Class Value Cash 7.11% Equity 92.89% Top Securities Holdings / Portfolio
Name Holding Value Quantity Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE7% ₹427 Cr 3,038,968
↑ 1,051,870 HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK6% ₹393 Cr 2,043,971 Hindustan Unilever Ltd (Consumer Defensive)
Equity, Since 30 Jun 24 | HINDUNILVR4% ₹263 Cr 1,121,657
↑ 317,705 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL4% ₹250 Cr 1,342,233 Axis Bank Ltd (Financial Services)
Equity, Since 30 Apr 25 | 5322154% ₹231 Cr 1,948,029
↑ 1,948,029 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹187 Cr 637,966 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹176 Cr 12,833,401 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | 5262993% ₹175 Cr 710,533 Intellect Design Arena Ltd (Technology)
Equity, Since 30 Jun 24 | INTELLECT3% ₹164 Cr 2,076,823
↑ 2,076,823 ICICI Bank Ltd (Financial Services)
Equity, Since 31 Jan 10 | ICICIBANK3% ₹164 Cr 1,148,695 7. L&T Business Cycles Fund
CAGR/Annualized return of 14.7% since its launch. Ranked 19 in Sectoral category. Return for 2024 was 36.3% , 2023 was 31.3% and 2022 was 5.3% . L&T Business Cycles Fund
Growth Launch Date 20 Aug 14 NAV (09 Jun 25) ₹44.0129 ↑ 0.60 (1.38 %) Net Assets (Cr) ₹998 on 30 Apr 25 Category Equity - Sectoral AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.43 Sharpe Ratio 0.07 Information Ratio 0.69 Alpha Ratio 0.98 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-18 Months (1%),18 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹17,288 31 May 22 ₹18,672 31 May 23 ₹22,476 31 May 24 ₹32,882 31 May 25 ₹36,313 Returns for L&T Business Cycles Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 12.8% 3 Month 21.6% 6 Month -2.5% 1 Year 12.4% 3 Year 27.3% 5 Year 29% 10 Year 15 Year Since launch 14.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 36.3% 2023 31.3% 2022 5.3% 2021 34.5% 2020 9.3% 2019 5.3% 2018 -17.5% 2017 45.6% 2016 3.2% 2015 3.5% Fund Manager information for L&T Business Cycles Fund
Name Since Tenure Gautam Bhupal 1 Jun 23 2 Yr. Sonal Gupta 1 Jun 23 2 Yr. Data below for L&T Business Cycles Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Financial Services 32.8% Industrials 26.49% Consumer Cyclical 16.48% Basic Materials 11.46% Energy 6.63% Technology 1.27% Real Estate 0.88% Asset Allocation
Asset Class Value Cash 4% Equity 96% Top Securities Holdings / Portfolio
Name Holding Value Quantity ICICI Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | ICICIBANK6% ₹61 Cr 425,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 18 | RELIANCE6% ₹56 Cr 401,700 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 31 Dec 22 | MCX5% ₹52 Cr 85,600
↓ -8,700 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Dec 16 | 5002515% ₹49 Cr 95,680 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | HDFCBANK5% ₹48 Cr 246,800 Power Finance Corp Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5328102% ₹25 Cr 603,200 Kotak Mahindra Bank Ltd (Financial Services)
Equity, Since 28 Feb 25 | KOTAKBANK2% ₹24 Cr 110,300 PB Fintech Ltd (Financial Services)
Equity, Since 31 Dec 23 | 5433902% ₹24 Cr 149,200 Power Mech Projects Ltd (Industrials)
Equity, Since 31 Oct 22 | POWERMECH2% ₹24 Cr 90,800 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 31 Jan 15 | AHLUCONT2% ₹23 Cr 274,908 8. Canara Robeco Infrastructure
CAGR/Annualized return of 15.3% since its launch. Return for 2024 was 35.3% , 2023 was 41.2% and 2022 was 9% . Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (09 Jun 25) ₹161.42 ↑ 1.32 (0.82 %) Net Assets (Cr) ₹837 on 30 Apr 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio 0.08 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,956 31 May 22 ₹20,052 31 May 23 ₹24,554 31 May 24 ₹42,289 31 May 25 ₹43,658 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 10.6% 3 Month 17.2% 6 Month -2% 1 Year 6.1% 3 Year 30.6% 5 Year 33.5% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 3.93 Yr. Shridatta Bhandwaldar 29 Sep 18 6.67 Yr. Data below for Canara Robeco Infrastructure as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 44.37% Utility 13.54% Basic Materials 10.26% Energy 8.83% Financial Services 6.7% Technology 4.4% Communication Services 3.04% Consumer Cyclical 2.7% Real Estate 1.54% Asset Allocation
Asset Class Value Cash 4.07% Equity 95.93% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT6% ₹52 Cr 154,401
↑ 5,000 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325555% ₹38 Cr 1,066,480 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹37 Cr 264,250
↑ 10,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹31 Cr 58,250 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004004% ₹30 Cr 785,000 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328984% ₹29 Cr 957,546 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN3% ₹29 Cr 370,000 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL3% ₹29 Cr 919,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Oct 23 | DIXON3% ₹28 Cr 17,200
↑ 250 Power Finance Corp Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5328103% ₹27 Cr 660,000 9. Nippon India Pharma Fund
CAGR/Annualized return of 20.6% since its launch. Ranked 35 in Sectoral category. Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (09 Jun 25) ₹510.384 ↑ 2.07 (0.41 %) Net Assets (Cr) ₹8,260 on 30 Apr 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 0.54 Information Ratio -0.22 Alpha Ratio -1.9 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹15,700 31 May 22 ₹14,354 31 May 23 ₹15,555 31 May 24 ₹23,205 31 May 25 ₹27,075 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 5.4% 3 Month 9.1% 6 Month -0.6% 1 Year 14.5% 3 Year 24.4% 5 Year 21.6% 10 Year 15 Year Since launch 20.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.18 Yr. Kinjal Desai 25 May 18 7.02 Yr. Data below for Nippon India Pharma Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 99.71% Asset Allocation
Asset Class Value Cash 0.29% Equity 99.71% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA14% ₹1,146 Cr 6,256,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB10% ₹791 Cr 1,298,808 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002576% ₹521 Cr 2,483,991
↓ -414,135 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹496 Cr 3,200,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹453 Cr 648,795 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY5% ₹434 Cr 3,662,170 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO4% ₹300 Cr 1,011,921 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434274% ₹292 Cr 3,627,277 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹283 Cr 2,831,564 Abbott India Ltd (Healthcare)
Equity, Since 31 May 11 | ABBOTINDIA3% ₹267 Cr 88,883
↓ -2,050 10. Invesco India Infrastructure Fund
CAGR/Annualized return of 11.3% since its launch. Ranked 24 in Sectoral category. Return for 2024 was 33.2% , 2023 was 51.1% and 2022 was 2.3% . Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (09 Jun 25) ₹65.48 ↑ 0.56 (0.86 %) Net Assets (Cr) ₹1,446 on 30 Apr 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio -0.11 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,721 31 May 22 ₹19,247 31 May 23 ₹23,000 31 May 24 ₹41,136 31 May 25 ₹41,519 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 9 Jun 25 Duration Returns 1 Month 13.2% 3 Month 21.5% 6 Month -3% 1 Year 3.4% 3 Year 30.5% 5 Year 32.1% 10 Year 15 Year Since launch 11.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.74 Yr. Sagar Gandhi 1 Mar 25 0.25 Yr. Data below for Invesco India Infrastructure Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 53% Basic Materials 9.07% Consumer Cyclical 8.32% Utility 6.89% Communication Services 6.72% Health Care 4.57% Technology 4.03% Energy 2.76% Financial Services 1.91% Real Estate 1.72% Asset Allocation
Asset Class Value Cash 0.81% Equity 99.19% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL7% ₹97 Cr 521,351 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328984% ₹61 Cr 1,975,592 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Sep 22 | DIXON4% ₹58 Cr 35,407
↑ 3,989 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | 5099304% ₹51 Cr 144,264 Indian Railway Catering And Tourism Corp Ltd (Industrials)
Equity, Since 30 Apr 24 | IRCTC4% ₹51 Cr 674,750
↑ 108,922 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA3% ₹50 Cr 40,213 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 24 | APOLLOHOSP3% ₹50 Cr 71,172 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹48 Cr 37,702
↓ -183 Delhivery Ltd (Industrials)
Equity, Since 31 Aug 24 | 5435293% ₹47 Cr 1,547,850
↑ 196,155 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 30 Nov 24 | POWERINDIA3% ₹47 Cr 32,412
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved